Morgan Stanley P Lx Pharma Inc. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $1,223 - $3,059	-10,197 Reduced 5.37%	179,616 $23,000
Q4 2022 Feb 14, 2023	SELL	$0.15 - $0.63 $6,643 - $27,903	-44,291 Reduced 18.92%	189,813 $30,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $3.08 $227,191 - $1.35 Million	-436,906 Reduced 65.11%	234,104 $152,000
Q2 2022 Oct 27, 2022	SELL	$1.9 - $4.18 $349,092 - $768,003	-183,733 Reduced 21.5%	671,010 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$1.9 - $4.18 $349,092 - $768,003	-183,733 Reduced 21.5%	671,010 $1.63 Million

Q1 2022 Oct 27, 2022	BUY	$3.54 - $8.3 $650,414 - $1.52 Million	183,733 Added 27.38%	854,743 $3.45 Million
Q1 2022 May 13, 2022	SELL	$3.54 - $8.3 $13,271 - $31,116	-3,749 Reduced 0.44%	854,743 $3.45 Million
Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $4.97 Million - $12.7 Million	646,659 Added 305.27%	858,492 $6.88 Million
Q3 2021 Nov 15, 2021	BUY	$12.22 - $21.28 $2.59 Million - $4.51 Million	211,833 New	211,833 $4.09 Million

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.